富血小板血浆减轻前交叉韧带重建供区疼痛的时间依赖性效应
该系统综述与Meta分析纳入4项研究共157例患者,评估富血小板血浆(PRP)对前交叉韧带重建(ACLR)自体移植物供区的影响。结果显示PRP在术后6个月和12个月降低VAS疼痛评分,但24个月时效应消失,且膝关节功能评分未改善。
要点
- PRP在ACLR术后6个月和12个月降低供区VAS疼痛评分,24个月时效应消失。
- PRP对供区疼痛的降低未达临床相关性,且未改善膝关节功能评分。
- 术后时间可预测PRP相关疼痛减轻程度(r²=0.98)。
核心结论
- PRP应用于骨-髌腱-骨供区可在术后一年内减轻膝痛,且效果随时间递减。
- 疼痛减轻未达临床相关性,也未带来更好的膝关节功能评分。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Web of Science、Embase、Scopus和Cochrane数据库。
- 纳入4项研究,共分析157例患者。
主要发现
- 单变量回归分析显示术后时间可预测PRP相关VAS疼痛评分降低(r²=0.98)。
关键数值与推荐
- 疼痛评估采用视觉模拟量表(VAS)。
- 功能评估采用膝关节功能评分。
临床怎么用
- PRP可用于ACLR术后一年内减轻供区疼痛,但需告知患者疼痛减轻未达临床相关性且功能无改善。
- 临床决策应权衡PRP的短期镇痛效果与缺乏功能获益。
局限性
- 仅纳入4项研究,样本量较小(157例患者)。
- 疼痛减轻未达临床相关性。
- PRP对膝关节功能无显著改善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anterior cruciate ligament reconstruction (ACLR) has a high incidence among sports players, and one important side effect of the surgery is graft donor site morbidity. Although some evidence suggests that application of platelet-rich plasma (PRP) during ACLR reduces pain and improves knee function, it is not a universal finding. PURPOSE: To perform a meta-analysis of previous studies testing the effects of PRP on donor site morbidity after ACLR. STUDY DESIGN: Systematic review and meta-analysis. METHODS: We reviewed PubMed (Medline), Web of Science, Embase, Scopus, and Cochrane databases to find studies testing the effects of PRP on the donor site of ACLR autograft. After identifying 4 studies, we conducted 2 meta-analyses, 1 for the effects of PRP on pain, assessed by visual analog scale (VAS), and the other for the functional knee scores. We also tested the ability of time after ACLR to predict the PRP-related reduction of pain. RESULTS: In the 4 studies identified, 157 patients were analyzed. Although the VAS score was lower with PRP at 6 months (raw mean difference [RMD], -0.97 [95% CI, -1.59 to -0.36]; P = .001) and 12 months (RMD, -0.61 [95% CI,-1.02 to -0.21]; P = .003), the effects of PRP disappeared at 24 months (RMD, -0.08 [95% CI,-0.38 to 0.22]; P = .586). A univariate regression analysis reinforced the ability of time after ACLR to predict the PRP-related reduction of VAS pain score (r2 = 0.98). However, knee function after ACLR was not improved by the use of PRP (standardized mean difference, 0.71 [95% CI,-0.17 to 1.60]; P = .114). CONCLUSION: PRP applied to a bone-patellar tendon-bone donor site could reduce knee pain within a year, and this reduction had a correlation with time, meaning that the effect of PRP decreased with time after surgery. However, pain reduction did not reach clinical relevance and did not lead to better functional knee scores.
引用
- de Andrade ALL, Sardeli AV, Garcia TA, et al. Time-Dependent Effect of Platelet-Rich Plasma in Reducing Donor-Site Pain After Anterior Cruciate Ligament Reconstruction. Am J Sports Med. 2020. PMID: 33253008. doi:10.1177/0363546520968289
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。